John Upegui
Physician Assistant · Houlton, MENPI 1811272990
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 74 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$225
- Novo Nordisk$143
- AstraZeneca$134
- Scilex Pharmaceuticals Inc.$93
- Boehringer Ingelheim$76
- Bayer$75
- plus $565 from 17 others
What the payments were for
- Food & beverage$1,311100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $225 |
| Novo Nordisk | 7 | $143 |
| AstraZeneca | 8 | $134 |
| Scilex Pharmaceuticals Inc. | 5 | $93 |
| Boehringer Ingelheim | 4 | $76 |
| Bayer | 4 | $75 |
| Redhill Biopharma Inc. | 5 | $69 |
| Lundbeck LLC | 3 | $66 |
| Paratek Pharmaceuticals, Inc. | 3 | $60 |
| Pfizer | 3 | $56 |
| Exact Sciences | 2 | $45 |
| GSK | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $28 |
| Pharmacosmos Therapeutics Inc. | 1 | $25 |
| Boston Scientific | 1 | $25 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Forte Bio-pharma LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Virtus Pharmaceuticals LLC | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
How this compares
$1,311 in reported general payments places this provider in the 90th percentile of 774 physician assistant providers in Maine.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 275 | $283,134 |
| JardianceEmpagliflozin | 67 | $93,178 |
| TrulicityDulaglutide | 62 | $85,722 |
| OzempicSemaglutide | 76 | $75,881 |
| XifaxanRifaximin | 21 | $67,813 |
| JanuviaSitagliptin Phosphate | 56 | $65,557 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $45,563 |
| MounjaroTirzepatide | 35 | $39,522 |
| EntrestoSacubitril/Valsartan | 23 | $36,367 |
| Breo ElliptaFluticasone/Vilanterol | 56 | $32,664 |
| Tresiba Flextouch U-100Insulin Degludec | 26 | $30,579 |
| FarxigaDapagliflozin Propanediol | 22 | $28,619 |
| XareltoRivaroxaban | 16 | $27,017 |
| LinzessLinaclotide | 19 | $26,778 |
| MyrbetriqMirabegron | 35 | $24,222 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $56 | $283,134275 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $19 | $125,24497 claims |
| Boehringer IngelheimJardiance, Tradjenta | $76 | $107,04698 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $30 | $97,325134 claims |
| Novo NordiskOzempic | $143 | $75,88176 claims |
| AstraZenecaFarxiga | $134 | $28,61922 claims |
| AbbVieLinzess | $225 | $26,77819 claims |
| Astellas Pharma US IncMyrbetriq | $28 | $24,22235 claims |
| Hikma Pharmaceuticals USABuprenorphine | $16 | $11,39663 claims |
| Redhill Biopharma Inc.Movantik | $69 | $8,52012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 774 physician assistant providers in Maine.
Other physician assistant in Houlton
- Christine ThomasHoulton$2K
- Lee BlandHoulton$1K
- Jane PelletierWells$34K
- Douglas RhodaMillinocket$11K
- Sydney ScottWaterville$8K
- Jessica HennenRockport$7K
- Elizabeth PritchardAugusta$6K
- Mayra Torres BrinkMonmouth$6K
- Emeline SuttieAugusta$6K
- Cathleen CassieAugusta$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.